Fol. Biol. 2017, 63, 13-19

https://doi.org/10.14712/fb2017063010013

The Effect of Ibuprofen on Cytokine Production by Mononuclear Cells from Schizophrenic Patients

Hanna Bessler1,2, D. Cohen-Terica2,3, M. Djaldetti1,2, P. Sirota2,3

1Laboratory for Immunology and Hematology Research, Rabin Medical Center, Hasharon Hospital, Petah-Tiqva, Israel
2The Sackler School of Medicine, Tel Aviv University, Ramat Aviv, Israel
3Abarbanel Mental Health Center, Bat Yam, Israel

Received April 2016
Accepted October 2016

References

1. Akiyama, K. (1999) Serum levels of soluble IL-2 receptor α, IL-6 and IL-1 receptor antagonist in schizophrenia before and during neuroleptic administration. Schizophr. Res. 37, 97-106. <https://doi.org/10.1016/S0920-9964(98)00140-6>
2. Bessler, H., Levental, Z., Karp, L., Modai, I., Djaldetti, M., Weizman, A. (1995) Cytokine production in drug-free and neuroleptic-treated schizophrenic patients. Biol. Psychiatry 38, 297-302. <https://doi.org/10.1016/0006-3223(94)00299-I>
3. Bessler, H., Ziyada, S., Bergman, M., Punsky, I., Sirota, L. (2002) Indomethacin and ibuprofen effect on IL-1ra production by mononuclear cells of preterm newborns and adults. Biol. Neonate 82, 73-77. <https://doi.org/10.1159/000063090>
4. Brown, A. S., Susser, E. S. (2002) In utero infection and adult schizophrenia. Ment. Retard. Dev. Disabil. Res. Rev. 8, 51-57. <https://doi.org/10.1002/mrdd.10004>
5. Dinarello, C. A. (1996) Biologic bases for interleukin-1 in disease. Blood 87, 2095-2147. <https://doi.org/10.1182/blood.V87.6.2095.bloodjournal8762095>
6. Eaton, W. W., Byrne, M., Ewald, H., Mors, O., Chen, C. Y., Agerbo, E., Mortensen, P. B. (2006) Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am. J. Psychiatry 163, 521-528. <https://doi.org/10.1176/appi.ajp.163.3.521>
7. el-Mallakh, R. S., Suddath, R. L., Wyatt, R. J. (1993) Interleukin-1 α and interleukin-2 in cerebrospinal fluid of schizophrenic subjects. Prog. Neuropsychopharmacol. Biol. Psychiatry 17, 383-391. <https://doi.org/10.1016/0278-5846(93)90072-Z>
8. Endres, S., Whitaker, R. E., Ghorbani, R., Strunk, T., Schult, C. (1996) Oral aspirin and ibuprofen increase cytokine-induced synthesis of IL-1β and tumor necrosis factor-α ex vivo. Immunology 87, 264-270. <https://doi.org/10.1046/j.1365-2567.1996.472535.x>
9. Ganguli, R., Yang, Z., Shurin, G., Chengappa, K. N., Brar, J. S., Gubbi, A. V., Rabin, B. S. (1994) Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness. Psychiatr. Res. 51, 1-10. <https://doi.org/10.1016/0165-1781(94)90042-6>
10. Ganguli, R., Brar, J. S., Chengappa, K. R., DeLeo, M., Yang, Z. W., Shurin, G., Rabin, B. S. (1995) Mitogen-stimulated interleukin-2 production in never-medicated, first-episode schizophrenic patients. The influence of age at onset and negative symptoms. Arch. Gen. Psychiatry 52, 668-672. <https://doi.org/10.1001/archpsyc.1995.03950200058014>
11. Gaughran, F., O’Neill, E., Sham, P., Daly, R. J., Shanahan, F. (2002) Soluble interleukin 2 receptor levels in families of people with schizophrenia. Schizophr. Res. 56, 235-239. <https://doi.org/10.1016/S0920-9964(01)00275-4>
12. Guy, W. (1976) ECDEU Assessment Manual for Psychopharmacology. US Department of Health, Education, and Welfare. National Institute of Mental Health. Rockville, MD
13. Haack, M., Hinze-Selch, D., Fenzel, T., Kraus, T., Kühn, M., Schuld, A., Pollmächer, T. (1999) Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis. J. Psychiatr. Res. 33, 407-418. <https://doi.org/10.1016/S0022-3956(99)00021-7>
14. Härtel, C., von Puttkamer, J., Gallner, F., Strunk, T., Schultz, C. (2004) Dose-dependent immunomodulatory effects of acetylsalicylic acid and indomethacin in human whole blood: potential role of cyclooxygenase-2 inhibition. Scand. J. Immunol. 60, 412-420. <https://doi.org/10.1111/j.0300-9475.2004.01481.x>
15. Kay, S. R., Opler, L. A., Lindenmayer, J. P. (1989) The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation. Br. J. Psychiatry Suppl. 7, 59-67. <https://doi.org/10.1192/S0007125000291514>
16. Kunz, M., Ceresér, K. M., Goi, P. D., Fries, G. R,, Teixeira, A. L,, Fernandes, B. S., Belmonte-de-Abreu, P. S., Kauer-Sant’Anna, M., Kapczinski, F., Gama, C. S. (2011) Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and antiinflammatory balance. Rev. Bras. Psiquiatr. 33, 268-274.
17. Lin, A., Kenis, G., Bignotti, S., Tura, G. J., De Jong, R., Bosmans, E., Pioli, R., Altamura, C., Scharpé, S., Maes, M. (1998) The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6. Schizophr. Res. 32, 9-15. <https://doi.org/10.1016/S0920-9964(98)00034-6>
18. Maes, M., Bosmans, E., Calabrese, J., Smith, R., Meltzer, H. Y. (1995) Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. J. Psychiatr. Res. 29, 141-152. <https://doi.org/10.1016/0022-3956(94)00049-W>
19. Maes, M., Bocchio, C. L., Bignotti, S., Battisa Tura, G., Pioli, R., Boin, F., Kenis, G., Bosmans, E., de Jongh, R., Lin, A., Racagni, G., Altamura, C. A. (2000) Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics. Eur. Neuropsychopharmacol. 10, 119-124. <https://doi.org/10.1016/S0924-977X(99)00062-0>
20. Maier, S. F., Watkins, L. R. (1995) Intracerebroventricular interleukin- 1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock. Brain Res. 695, 279-282. <https://doi.org/10.1016/0006-8993(95)00930-O>
21. Mansilla-Rosello, A., Ferron-Orihuela, J. A., Ruiz-Cabello, F., Garrote-Lara, D., Fernandez-Mondejar, E., Delgado- Carrasco, M. L. (1997) Differential effects of IL-1β and ibuprofen after endotoxic challenge in mice. J. Surg. Res. 67, 199-204. <https://doi.org/10.1006/jsre.1996.4982>
22. Müller, N., Riedel, M., Scheppach, C., Brandstätter, B., Sokullu, S., Krampe, K., Ulmschneider, M., Engel, R. R., Möller, H. J., Schwarz, M. J. (2002) Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia. Am. J. Psychiatry 159, 1029-1034. <https://doi.org/10.1176/appi.ajp.159.6.1029>
23. Müller, N. (2014) Immunology of schizophrenia. Neuroimmunomodulation 21, 109-116. <https://doi.org/10.1159/000356538>
24. Naudin, J., Capo, C., Giusano, B., Mege, J. L., Azorin, J. M. (1997) A differential role for interleukin-6 and tumor necrosis factor-α in schizophrenia? Schizophr. Res. 26, 227-233. <https://doi.org/10.1016/S0920-9964(97)00059-5>
25. Paccani, S. R., Boncristiano, M., Ulivieri, C., D’Elios, M. M., Del Prete, G., Baldari, C. T. (2002) Nonsteroidal anti-inflammatory drugs suppress T-cell activation by inhibiting p38 MAPK induction. J. Biol. Chem. 277, 1509-1513. See comment in PubMed Commons below <https://doi.org/10.1074/jbc.M110676200>
26. Potvin, S., Stip, E., Sepehry, A. A., Gendron, A., Bah, R., Kouassi, E. (2008) Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol. Psychiatry 63, 801-808. <https://doi.org/10.1016/j.biopsych.2007.09.024>
27. Qui, H. B., Pan, J. Q., Zhao, Y. G., Chen, D. C. (1997) Effects of dexamethasone and ibuprofen on LPS-induced gene expression of TNFα, IL-1β, and MIP-1α in rat lung. Zhongguo Yao Li Xue Bao 18, 165-168.
28. Rothermundt, M., Arolt, V., Weitzsch, C., Eckhoff, D., Kirchner, H. (1998) Immunological dysfunction in schizophrenia: a systematic approach. Neuropsychobiology 37, 186-193. <https://doi.org/10.1159/000026501>
29. Rothwell, N. J., Hopkins, S. J. (1995) Cytokines and the nervous system II: Actions and mechanisms of action. Trends Neurosci. 18, 130-136. <https://doi.org/10.1016/0166-2236(95)93890-A>
30. Schwarz, M. J., Muller, N., Riedel, M., Ackenheil, M. (2001) The Th2-hypothesis of schizophrenia: a strategy to identify a subgroup of schizophrenia caused by immune mechanisms. Med. Hypotheses 56, 483-486. <https://doi.org/10.1054/mehy.2000.1203>
31. Sirota, P. (1990) Is schizophrenia an autoimmune disease? Isr. J. Med. Sci. 26, 694-697.
32. Sirota, P., Schild, K., Elizur, A., Djaldetti, M., Fishman, P. (1995) Increased interleukin-1 and interleukin-3 like activity in schizophrenic patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 19, 75-83. <https://doi.org/10.1016/0278-5846(94)00106-R>
33. Sirota, L., Shachman, D., Punsky, I., Bessler, H. (2001) Ibuprofen affects pro- and anti-inflammatory cytokine production by mononuclear cells of preterm newborns. Biol. Neonate 79, 103-108. <https://doi.org/10.1159/000047075>
34. Sirota, P., Meiman, M., Herschko, R., Bessler, H. (2005) Effect of neuroleptic administration on serum levels of soluble IL-2 receptor-α and IL-1 receptor antagonist in schizophrenic patients. Psychiatry Res. 134, 151-159. <https://doi.org/10.1016/j.psychres.2004.04.012>
35. Sirota, P., Hadi, E., Djaldetti, M., Bessler, H. (2015) Difference in inflammatory cytokine production by mononuclear cells from obese and non-obese schizophrenic patients. Acta Psychiatr. Scand. 132, 301-305. <https://doi.org/10.1111/acps.12396>
36. Stuhlmeier, K. M., Li, H., Kao, J. J. (1999) Ibuprofen: new explanation for old phenomenon. Biochem. Pharmacol. 57, 313-320. <https://doi.org/10.1016/S0006-2952(98)00301-3>
37. Toyooka, K., Watanabe, Y., Iritani, S., Shimizu, E., Iyo, M., Nakamura, R., Asama, K., Makifuchi, T., Kakita, A., Takahashi, H., Someya, T., Nawa, H. (2003) A decrease in interleukin-1 receptor antagonist expression in the prefrontal cortex of schizophrenic patients. Neurosci. Res. 46, 299-307. <https://doi.org/10.1016/S0168-0102(03)00093-2>
38. Zalcman, S., Green-Johnson, J. M., Murray, L., Nance, D. M., Dyck, D., Anisman, H., Greenberg, A. H. (1994) Cytokine specific central monoamine alterations induced by interleukin-1, -2 and -6. Brain Res. 643, 40-49. <https://doi.org/10.1016/0006-8993(94)90006-X>
front cover

ISSN 0015-5500 (Print) ISSN 2533-7602 (Online)

Open access journal

Submissions

Archive